🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK NHS GLP-1 prescribing — 12 month update Page 3

UK NHS GLP-1 prescribing — 12 month update

emily_PDX Mon, Oct 20, 2025 at 1:29 AM 28 replies 1,548 viewsPage 3 of 6
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Oct 21, 2025 at 10:21 AM#11
claudia_zurich said:
It is worth asking what the claim would look like if it were false.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

I would rather be corrected than agreed with, if it comes to it.

15 15maya_sedona, stefan_berlin, Dr.EM_Chicago and 12 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Oct 22, 2025 at 6:44 AM#12
Dr.EndoIndy said:
My experience ordering cross-border ordering internationally: I've ordered from an Australian compounder.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

Last edited: Oct 22, 2025 at 12:44 PM
14 14wei_SG, cory_ATX, lori_vegas and 11 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Oct 23, 2025 at 3:08 AM#13
claudia_zurich said:
It is worth asking what the claim would look like if it were false.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

13 13mike_mod, SarahChen_PharmD, sarah.morrison and 10 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 23, 2025 at 11:32 PM#14

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Happy to go further on any of that.

Last edited: Oct 24, 2025 at 1:32 AM
12 12KarenAZ_mom, zoe_NC, Dr.ObesityLA and 9 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 24, 2025 at 7:57 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

11 11PurityPaulOR, MaxMetOK, MounjBrad and 8 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register